Max Perilstein

Appearances

TOTAL NEOADJUVANT THERAPY IN DISTAL PANCREATIC ADENOCARCINOMA: DOES LOCATION IMPACT THERAPY RESPONSE?
Date
May 20, 2024
The role of total neoadjuvant therapy (TNT) in pancreatic ductal adenocarcinoma (PDAC) remains controversial with mixed data in the literature…
Presenter
Andrew Crocker
Speakers
Maryclare Taylor
Emily Papai
Max Perilstein
Malek Maddah
Karen Ruth
Anthony Villano
Sanjay Reddy
UNDERSTANDING FRAGMENTED PANCREATIC CANCER CARE IN PATIENTS RECIEVING NEOADJUVANT THERAPY: ARE SOCIODEMOGRAPHIC DISPARITIES PREDICTIVE OF PATIENTS RECEIVING FRAGMENTED CARE?
Date
May 20, 2024
INTRODUCTION: Fragmented Care (FC), care at multiple centers, is an emerging area of study in oncologic care. We examined a cohort of pancreatic cancer patients who received neoadjuvant therapy (NAT) to evaluate if sociodemographic disparities play a predictive role in receiving FC…
Presenter
Maryclare Taylor
Speakers
Andrew Crocker
Emily Papai
Max Perilstein
Malek Maddah
Karen Ruth
Anthony Villano
Sanjay Reddy